Low-Dose (17.5 mg/Day) Acitretin: Comparable Efficacy Without the Side Effects?

NCT01228409 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Psoriasis

Interventions

DRUG: Acitretin 17.5 mg/day

Sponsor

Frankel, Amylynne, M.D.

Collaborators

[object Object]